Accrued and Other Liabilities (Tables)
|
9 Months Ended |
Oct. 02, 2026 |
| Accrued Liabilities [Abstract] |
|
| Schedule of Accrued and Other Liabilities |
Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | October 2, 2026 | | December 31, 2025 | | Current | | Noncurrent | | Current | | Noncurrent | | (In thousands) | | Accrued taxes and deferred tax liabilities | $ | 66,857 | | | $ | 341,871 | | | $ | 53,728 | | | $ | 182,898 | | | Compensation and related benefits | 87,131 | | | 49,415 | | | 68,535 | | | 52,706 | | | Asbestos liability | 43,206 | | | 248,828 | | | 42,242 | | | 269,829 | | | Contract liabilities | 33,098 | | | — | | | 19,663 | | | — | | | Lease liabilities | 24,779 | | | 113,310 | | | 22,081 | | | 88,141 | | | Warranty liability | 12,854 | | | — | | | 12,573 | | | — | | | Third-party commissions | 16,209 | | | — | | | 19,371 | | | — | | | Restructuring liability | 8,281 | | | 351 | | | 17,297 | | | 319 | | | Accrued interest | 19,959 | | | — | | | 8,570 | | | — | | | | | | | | | | | Dividends payable | 10,351 | | | — | | | 6,098 | | | — | | | Other | 45,494 | | | 39,551 | | | 31,828 | | | 63,343 | | | $ | 368,219 | | | $ | 793,326 | | | $ | 301,986 | | | $ | 657,236 | |
|
| Schedule of Product Warranty Liability |
A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows: | | | | | | | | | | | | | Nine Months Ended | | October 2, 2026 | | October 3, 2025 | | (In thousands) | | Warranty liability, beginning of period | $ | 12,573 | | | $ | 12,794 | | | Accrued warranty expense | 7,231 | | | 6,526 | | | Changes in estimates related to pre-existing warranties | 1,427 | | | 906 | | | Cost of warranty service work performed | (8,681) | | | (9,102) | | | | | | | Foreign exchange translation effect and other | 304 | | | 2,201 | | | Warranty liability, end of period | $ | 12,854 | | | $ | 13,325 | |
|
| Schedule of Restructuring Reserve by Type of Cost |
A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended October 2, 2026 | | Balance at Beginning of Period | | Charges | | Payments | | Foreign Currency Translation and Other | | Balance at End of Period | | (In thousands) | | Americas: | | | | | | | | | | Termination benefits(1) | $ | 8,827 | | | $ | 2,751 | | | $ | (6,438) | | | $ | (1,074) | | | $ | 4,066 | | Facility closure costs and other(2) | 1,677 | | 25,420 | | | (25,644) | | | (418) | | | 1,035 | | Subtotal | 10,504 | | 28,171 | | | (32,082) | | | (1,492) | | | 5,101 | Non-cash charges(2) | | | 10,196 | | | | | | | | | | | 38,367 | | | | | | | | | EMEA & APAC: | | | | | | | | | | Termination benefits(1) | 6,223 | | | (285) | | | (4,472) | | | 1,195 | | | 2,661 | | Facility closure costs and other(2) | 889 | | 1,725 | | | (2,153) | | | 409 | | | 870 | | | Subtotal | 7,112 | | 1,440 | | | (6,625) | | | 1,604 | | | 3,531 | | | Non-cash charges | | | — | | | | | | | | | | | 1,440 | | | | | | | | | | | | | | | | | | | Total | $ | 17,616 | | | 29,611 | | | $ | (38,707) | | | $ | 112 | | | $ | 8,632 | | Non-cash charges(2) | | | 10,196 | | | | | | | | | Total Provision | | | $ | 39,807 | | | | | | | |
(1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets, costs associated with disposing of discontinued products and other costs in connection with the closure and optimization of facilities and product lines.
|